The Sackler family funds top-tier museums (the Met, the Tate, the Smithsonian), universities (Princeton, Cambridge), and scientific research institutes (the Mayo Clinic, the National Academy of Sciences). Where does their cash come from? Writing in Esquire, Christopher Glazek tells us: pharmaceuticals — these days, largely OxyContin, which generates over a billion dollars in sales each year on the back of a campaign built on misleading both doctors and the public about its addictive potential. Over 200,000 people have now died of OxyContin overdoses, and many more from heroin after first becoming addicted to opioids via Oxy.
The Sacklers have experience turning an addictive drug into a household name. In the 1960s, family patriarch Arthur Sackler did it with benzodiazepene:
In the 1960s, Arthur was contracted by Roche to develop an advertising strategy for a new antianxiety medication called Valium. This posed a challenge, because the effects of the medication were nearly indistinguishable from those of Librium, another Roche tranquilizer that was already on the market. Arthur differentiated Valium by audaciously inflating its range of indications. Whereas Librium was sold as a treatment for garden- variety anxiety, Valium was positioned as an elixir for a problem Arthur christened “psychic tension.” According to his ads, psychic tension, the forebear of today’s “stress,” was the secret culprit behind a host of somatic conditions, including heartburn, gastrointestinal issues, insomnia, and restless-leg syndrome. The campaign was such a success that for a time Valium became America’s most widely prescribed medication—the first to reach more than $100 million in sales. Arthur, whose compensation depended on the volume of pills sold, was richly rewarded, and he later became one of the first inductees into the Medical Advertising Hall of Fame.
Later, the company would do the something similar with OxyContin and pain, when it “rebranded pain relief as a sacred right: a universal narcotic entitlement available not only to the terminally ill but to every American.”